BFRI
Closed
Biofrontera Inc
0.688
-0.024 (-3.37%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.7115
Day's Range: 0.640101 - 0.7
Send
sign up or login to leave a comment!
When Written:
0.61
Biofrontera Inc. is a biopharmaceutical company that focuses on the development and commercialization of dermatological drugs and medical devices for the treatment of skin diseases and conditions. The company's flagship product is Ameluz, a prescription drug used in the treatment of actinic keratosis, a type of skin cancer. Biofrontera also produces the BF-RhodoLED, a medical device used in photodynamic therapy. The company was founded in 1997 and is headquartered in Leverkusen, Germany, with a subsidiary in Woburn, Massachusetts. It is listed on the NASDAQ stock exchange under the ticker symbol BFRA.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








